Himed and Lithoz Enter Medical 3D Printing Materials Research Partnership
Advancing 3D-printed medical implants depends on the steady progress of leading-edge printer technologies, as well as the skillful development of the raw materials used in those technologies. Appreciating that these crucial factors must work together, Himed (www.himed.com), a New York-based biomaterials manufacturer serving dental and orthopedic implant markets worldwide, and Lithoz (www.lithoz.com), a global market leader in 3D printing based in Austria, have teamed up to develop new bioceramic feedstocks.
Himed and Alfred University Partner to Better Understand Synthesis and Production of Critical Biomaterials
Himed and Alfred University’s New York State College of Ceramics (NYSCC) recently announced a multi-year collaborative research agreement that aims to advance and optimize techniques used in the production of calcium phosphate biomaterials.
Such materials play a critical role in the repair of hard tissues in applications ranging from dental implants to bone grafting and bone replacement. The global market for dental implants alone, already a $4.6 billion industry, is expected to continue to grow by 9% annually through 2027. Improvements in bioactive healing through better biomaterials will benefit patients from all walks of life, including an aging global population who will come to rely on such materials for an improved quality of life.